13F Insight
DOSSIER · 13F Holders · Q2 2026

NEWAMSTERDAM PHARMA COMPANY

12 institutions still hold NEWAMSTERDAM PHARMA COMPANY as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP N62509117·12 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$30M
visible holders
Holders
12
filers reporting
Concentration
35.81%
Frazier Life Sciences Management, L.P. #1
top holder share
AI Holders Summary · Q2 2026

12 institutions reported NEWAMSTERDAM PHARMA COMPANY in Q2 2026. Frazier Life Sciences Management, L.P. leads at 35.8% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Frazier Life Sciences Management, L.P.
CIK 0001892134
$11M500K0.23%Q2 202602
RA CAPITAL MANAGEMENT, L.P.
CIK 0001346824
$7M333K0.06%Q2 202603
Affinity Asset Advisors, LLC
CIK 0001773195
$5M245K0.24%Q2 202604
Bain Capital Life Sciences Investors, LLC
CIK 0001703031
$2M100K0.13%Q2 202605
DEERFIELD MANAGEMENT COMPANY, L.P.
CIK 0001009258
$2M93K0.03%Q4 202506
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
$2M75K0.00%Q2 202607
ARISTEIA CAPITAL, L.L.C.
CIK 0001080171
$343K16K0.00%Q2 202608
WOLVERINE ASSET MANAGEMENT LLC
CIK 0001279891
$319K15K0.00%Q2 202609
Vestcor Inc
CIK 0001536925
$131K7K0.00%Q1 202610
CIBC Private Wealth Group LLC
CIK 0001298088
$25K1K0.00%Q4 202511
UBS Group AG
CIK 0001610520
$9K4430.00%Q2 202612
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025